Dicyclomine Hydrochloride Injection, Solution
Product Images NDC 51662-1559

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 51662-1559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch Labeling (51662 1559 2 Pouch Label)

Label for Dicyclomine Hydrochloride Injection, USP 20 mg per 2 mL (10 mg per mL) in a 2 mL vial. The label includes NDC 51662-1559-2, lot number 123456, and expiration date 2025-01-01. It states the product is for intramuscular use only, sterile, and manufactured by HF Acquisition Co., LLC, Mukilteo, WA. Storage instructions and a QR code are also visible.*

FDA Label Image

Serialized Case Labeling (51662 1559 3 Serialized Labeling)

A small rectangular label for DICYCLOMINE HYDROCHLORIDE injection, solution, 10 mg/mL, with a Data Matrix barcode and serialized identifiers. The label states distribution by HF Acquisition Co., LLC in Mukilteo, WA 98275, and includes a notation 'RX ONLY' indicating prescription use.*

FDA Label Image

Case Labeling (5166201559 3 Case Label)

Label for DICYCLOMINE HYDROCHLORIDE Injection, USP 20 mg per 2 mL (10 mg per mL) in a 2 mL vial, box of 5, for intramuscular use. The label includes NDC 51662-1559-3, lot number, expiration date 2025-01-01, manufacturer HF Acquisition Co LLC, Mukilteo, WA. Storage instructions and sterility details are provided.*

FDA Label Image

Adverse (Adverse)

Data table showing the percentage incidence of various adverse events reported for Dicyclomine Hydrochloride 40 mg four times a day compared to placebo. The events listed include dry mouth, dizziness, blurred vision, nausea, somnolence, asthenia, and nervousness with corresponding percentages for both treatment and placebo groups.*

FDA Label Image

Hs (Hs)

A data table showing product code 842102 with unit of sale as NDC 63323-842-02, packaged in a carton of 5. The strength is listed as 20 mg per 2 mL (10 mg per mL), and each unit is a 2 mL single-dose vial with NDC 63323-842-21.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of Dicyclomine Hydrochloride, showing its molecular composition with cyclohexane rings and ethylamine groups, including the hydrochloride component.*

FDA Label Image

Vial Labeling (Vial Labeling)

Label for Dicyclomine Hydrochloride Injection USP, 10 mg per mL, 2 mL single-dose vial for intramuscular use. The label includes the NDC number 63323-842-21, batch number 403327, manufacturing details indicating product made in India by HF Acquisition Co LLC, DBA HealthFirst. The label features a barcode and dosing instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.